AI can now address misdiagnosis of heart disease by overcoming gender-based differences in symptoms

MedTechPartner content

According to data projections from the World Population Review, the median age of humanity is 31.0 years in 2020. This is a notable increase from 70 years ago, when the median age of humanity was only 23.6 years. These data indicate that improving access to health facilities allows humanity to live longer.

However, this brings its own challenges, such as lifestyle and age-related illnesses. In both cases, cardiovascular diseases are the primary cause of concern for the world’s population. According to the WHO, cardiovascular diseases lead to the death of approximately 17.9 million people each year.

Due to the diagnostic difficulty it presents and the enduring belief that cardiovascular disease (CVD) primarily affects men, cardiovascular disease in women continues to go undiagnosed and untreated. Although sex-related risk variables have already been identified, there is a lack of clinical applicability, resulting in women with CVD being misdiagnosed and poorly managed. To optimize care and significantly reduce morbidity and mortality in this patient population, it is essential to address gender-specific symptomatology and risk factors.

This is a worrying trend that requires urgent input from deep technology and AI to present concrete solutions.

These challenges present a unique opportunity for aspiring and existing MedTech AI entrepreneurs. Among the five main recognized disciplines of deep technology; Biotech and MedTech are filling the innovation void left by the underperforming traditional healthcare sector.

According to the CEO of Philips Frans van Houten“The collection of pre-existing medical data is already more than enough to be exploited by AI to develop technological solutions for cardiovascular diseases in people. The only thing required is to start acting on it and not to sit on data that can be of great use for deep technology research.

Framing deep tech and AI products as disruptive in a negative sense does not do justice to the useful role these solutions can potentially play in helping physicians monitor health indicators and prescribe preliminary diagnoses. Disruptor in most cases is an added value for better results.

Companies like 24Sense do a great job doing this. They have developed a unique sensor system and software based on artificial intelligence in 2020. They aim to introduce their shoulder strap technology for monitoring people’s cardiovascular health. The goal is to more accurately detect CVD in women.

Unlike other ECG devices, the owner of 24Sens claims that their wearable guarantees better quality data recording and documentation, combined with a high level of wearing comfort.

The MedTech startup scene in Europe is a booming sector. Founder of Rajat Khare of Boundary Holding, based in Luxembourg, is constantly investing in various MedTech companies across Europe. The innovative solution proposed by 24Sens caught the entrepreneur’s attention. Gunter Grabher appreciated that very much and now the plan is to invest over 4.5 million euros in their joint venture.

We need more such innovators who are dynamic and understand the problem not only at the industry or sector level, but also at the micro level like gender, age, demographics and other factors. ignored.